Immunometabolic biomarkers of inflammation in Behçet's disease: relationship with epidemiological profile, disease activity and therapeutic regimens

Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease

(2015) Luca Cantarini et al.   AUTOIMMUNITY REVIEWS

The Cellular and Molecular Basis of Translational Immunometabolism

(2015) Giuseppe Danilo Norata et al.   IMMUNITY

Differential impact of high and low penetrance TNFRSF1A gene mutations on conventional and regulatory CD4+ T cell functions in TNFR1-associated periodic syndrome

(2015) Valentina Pucino et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Leptin in autoimmune diseases

(2015) Claudio Procaccini et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants

(2015) Veronica De Rosa et al.   NATURE IMMUNOLOGY

Serum amyloid-A in Behçet’s disease

(2014) Antonio Vitale et al.   CLINICAL RHEUMATOLOGY

The labyrinth of autoinflammatory disorders: a snapshot on the activity of a third-level center in Italy

(2014) Luca Cantarini et al.   CLINICAL RHEUMATOLOGY

Proinflammatory Cytokines and C-Reactive Protein in Uveitis Associated with Behçet’s Disease

(2014) Marina Mesquida et al.   MEDIATORS OF INFLAMMATION

Biological Treatments in Behçet’s Disease: Beyond Anti-TNF Therapy

(2014) Francesco Caso et al.   MEDIATORS OF INFLAMMATION

Leptin modulates autophagy in human CD4+CD25− conventional T cells

(2014) Silvana Cassano et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

IL-22-secreting Th22 and IFN-γ-secreting Th17 cells in Behçet's disease

(2014) Esin Aktas Cetin et al.   Modern Rheumatology

Neuro-Endocrine Networks Controlling Immune System in Health and Disease

(2014) Claudio Procaccini et al.   Frontiers in Immunology

Behçet's Syndrome

(2013) Gulen Hatemi et al.   RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

Leptin-Induced mTOR Activation Defines a Specific Molecular and Transcriptional Signature Controlling CD4+ Effector T Cell Responses

(2012) C. Procaccini et al.   JOURNAL OF IMMUNOLOGY

Relationships of HLA-B51 or B5 genotype with Behçet's disease clinical characteristics: systematic review and meta-analyses of observational studies

(2012) Carla Maldini et al.   RHEUMATOLOGY

Platelet soluble CD40L and matrix metalloproteinase 9 activity are proinflammatory mediators in Behçet disease patients

(2011) I. Fernández Bello et al.   THROMBOSIS AND HAEMOSTASIS

An Oscillatory Switch in mTOR Kinase Activity Sets Regulatory T Cell Responsiveness

(2010) Claudio Procaccini et al.   IMMUNITY

Molecular mechanism and function of CD40/CD40L engagement in the immune system

(2009) Raul Elgueta et al.   IMMUNOLOGICAL REVIEWS

Soluble tumour necrosis factor receptors sTNFR1 and sTNFR2 are produced at sites of inflammation and are markers of arthritis activity in Behçet's disease

(2008) B. Turan et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY